Gene Query: AGO4

Dataset Description Geneva Score
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 29.65
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 27.52
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 24.99
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 22.69
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 22.53
HNRNPL and its RNA Targets in Prostate Cancer 19.39
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 19.39
Role for citron kinase in prostate cancer growth 17.72
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 16.47
Transcriptomes of human monocytes after ex vivo exposure to uric acid 16.17
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 15.26
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 15.21
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 15.04
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 14.67
Human neutrophil genome during PMA- and E. coli encounter-induced activation 14.67
Dtx3L and Androgen Signaling in Prostate Cancer 14.6
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 14.4
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 14.39
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 14.39
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 13.95
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 13.89
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 13.7
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 13.7
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 13.18
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 13.18
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 13.07
AR-independent prostate cancer is sustained through FGF signaling 12.83
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 12.74
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 12.73
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 12.69
Lysine benzoylation is a novel histone mark [RNA-seq] 12.64
Lysine benzoylation is a novel histone mark 12.64
LncRNA expression profiling of ischemic stroke patients 11.93
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 11.89
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 11.89
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 11.53
Total RNA-seq in ALL-SIL upon TLX1 knockdown 11.48
Global transcriptome analysis of HAP1 cells 11.37
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 11.3
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 11.28
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 11.22
CircRNAome diversity in human mature B-cells, T-cells and monocytes 11.18
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 10.93
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 10.93
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 10.73
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 10.73
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 10.59
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 10.47
Genome-wide functional assessment of enhancer activities in the human genome 10.13
Gene expression profiling of leukemia cells following asparagine depletion 10.03
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 9.96
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 9.84
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 9.79
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 9.76
Gene expression changes after LOC550643 silencing 9.67
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 9.45
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 9.37
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 9.37
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 9.23
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 9.21
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 9.17
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 9.15
The landscape of alternative splicing in aggressive prostate cancers 8.87
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 8.78
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 8.71
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 8.57
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 8.57
Intron retention induced by microsatellite expansions as a disease biomarker. 8.5
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 8.45
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 8.45
Trascriptome of thyroid cancer-induced macrophages 8.44
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 8.43
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 8.42
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 8.19
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 8.14
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 8.13
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 8.1
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 8.06
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 8.06
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 7.98
WRN knockout effects upon gene expression in SW48 and OVK18 7.95
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 7.91
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 7.9
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 7.82
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 7.76
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 7.75
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 7.75
Intrahepatic MAIT cell gene expression revealed by RNA-seq 7.71
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 7.63
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 7.63
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 7.46
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 7.42
RNA-seq analysis of uveal melanoma cells treated with FR900359 7.38
RNA-seq of resting and activated CD4+ T cells +-JQ1 7.26
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 7.25
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 7.21
Short and Long RNA sequencing of human mature erythrocytes 7.13
Global epigenomic reconfiguration during mammalian brain development 7.07
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 7.06
Examining serotonergic neuron differentiation from human iPSCs 7.05
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 7.01
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 7.01
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 7.0
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 6.99
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 6.99
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 6.94
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 6.75
RNA-seq data from human lymphoma cell lines 6.75
ChIP-seq and RNA-seq from human lymphoma cell lines 6.75
Hijacking of stress response machinery by oncogenes in acute leukaemia 6.72
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 6.72
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 6.7
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 6.69
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 6.68
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 6.57
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 6.54
ZIKV infection of monocytes activates inflammasome pathways 6.52
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 6.52
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 6.52
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 6.51
Gene expression changes associated with resistance to tagraxofusp (SL-401) 6.5
Transcriptome analysis of U87 cells upon LINC00152 knockdown 6.47
The pause-initiation limit restricts transcription activation in human cells 6.46
Chromatin-informed inference of transcriptional programs in gynecologic cancers 6.42
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 6.42
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 6.39
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 6.38
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 6.38
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 6.37
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 6.36
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 6.36
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 6.33
TT-Seq captures the human transient transcriptome 6.29
Aging-associated patterns in the expression of human endogenous retroviruses 6.29
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 6.25
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 6.25
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 6.23
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 6.18
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 6.16
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 6.13
Defective structural RNA processing in relapsing-remitting multiple sclerosis 6.08
MYCL and EP400 are required for Max and MCPyV mediated gene activation 6.03
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 5.99
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 5.99
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 5.91
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 5.87
Paxillin regulates genomic networks in prostate cancer [LNCaP] 5.86
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 5.84
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 5.83
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 5.79
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 5.79
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 5.78
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 5.78
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 5.71
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 5.71
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 5.69
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 5.69
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 5.62
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 5.61
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 5.61
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 5.58
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 5.56
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 5.43
A map of gene expression in neutrophil-like cell lines 5.39
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 5.39
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 5.35
Transcriptome analysis in Neobractatin treated cells 5.34
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 5.34
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 5.27
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 5.27
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 5.22
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 5.21
RNA-seq of YB5 cells treated with Proscillaridin A 5.19
LNCaP treated with iBET 5.14
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 5.12
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 5.12
Primary Human B-cell Temporal Response to CD40L Stimulation 5.1
Widespread regulated alternative splicing of single codons accelerates proteome evolution 5.07
Pharmacologic inhibition of STAT5 in AML 5.06
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 5.06
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 5.01
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 4.98
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 4.98
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 4.94
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.92
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 4.89
SETBP1-WT and SETBP1-G870S epigenetic landscapes 4.89
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 4.88
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 4.86
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 4.84
Identification of Atrial Fibrillation associated genes and functional non-coding variants 4.83
Landscape of H3K4me3 in human CD19 cells 4.78
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 4.74
Total RNA-seq in ALL-SIL upon JQ1 inhibition 4.73
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 4.71
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 4.69
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 4.65
BACH2 in human plasma cell fate decision 4.61
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 4.59
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 4.58
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 4.56
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 4.56
EWSR1 influences alternative splicing through direct and indirect mechanisms 4.55
Integrating single-cell transcriptomic data across different conditions, technologies, and species 4.5
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.5
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.5
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 4.48
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 4.48
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 4.47
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 4.46
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 4.45
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 4.44
naive T cell heterogeneity after neonatal thymectomy 4.4
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 4.4
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 4.4
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 4.39
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 4.39
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 4.32
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 4.32
RNA Sequencing of Human iPS derived Cardiomyocytes 4.31
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 4.31
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 4.28
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.28
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 4.26
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 4.23
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 4.22
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 4.22
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.22
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.22
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 4.22
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 4.22
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 4.17
RNA sequencing of matched nephrectomy samples [RNA-seq] 4.16
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 4.16
Transcriptome analysis of peripheral blood monocytes 4.13
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 4.12
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 4.12
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 4.1
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 4.08
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 4.06
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 4.03
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 3.97
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.94
Region-specific Innate Antiviral Responses of the Human Epididymis 3.94
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 3.93
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 3.91
Endothelial gene expression analysis 3.85
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 3.85
Microglia innatly develop within cerebral organoids 3.85
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 3.84
Dynamic reorganization of nuclear architecture during human cardiogenesis 3.84
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 3.84
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 3.81
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 3.78
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 3.76
In situ CAPTURE of chromatin interactions by biotinylated dCas9 3.76
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 3.76
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 3.76
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 3.75
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 3.74
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 3.74
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 3.73
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 3.73
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 3.7
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 3.66
TAF1 is critical for AE driven leukemogenesis 3.66
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 3.65
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.65
Hypoxic transcriptome of SQ20B human head and neck cancer cells 3.57
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 3.56
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 3.55
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 3.52
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 3.49
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 3.49
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 3.45
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 3.43
Transcription control by the ENL YEATS domain in acute leukemia 3.43
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.42
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 3.42
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.39
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.39
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 3.38
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 3.38
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 3.36
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 3.35
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 3.34
RNA-sequencing of human tendon after injury 3.32
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 3.32
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 3.29
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 3.29
Transcriptome analysis upon C6orf203 silencing 3.26
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 3.22
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 3.22
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 3.22
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 3.22
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 3.21
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.21
Regionally specified human pluripotent stem cell-derived astrocytes 3.2
Paxillin regulates genomic networks in prostate cancer [C4-2] 3.2
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 3.17
Proliferation-correlated expression 3.13
Effect of PBK knockdown on C4-2 cell transcriptome 3.13
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 3.12
Expression and functions of long noncoding RNAs during human T helper cell differentiation 3.12
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 3.1
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 3.09
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 3.08
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 3.06
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 3.02
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.0
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 3.0
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 2.99
Identification of long noncoding RNAs in T-ALL cell lines 2.96
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 2.95
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 2.94
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 2.93
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 2.92
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.91
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 2.9
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 2.9
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 2.9
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.88
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 2.87
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 2.85
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 2.84
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 2.83
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 2.8
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 2.75
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 2.74
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 2.74
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 2.72
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.71
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.71
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.68
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.68
Dissecting neural differentiation regulatory networks through epigenetic footprinting 2.67
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 2.66
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.65
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 2.65
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.58
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 2.54
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 2.54
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 2.51
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 2.42
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 2.39
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.39
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 2.37
Measure transcript integrity using RNA-seq data 2.28
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.26
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 2.22
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 2.22
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.18
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.16
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.16
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 2.15
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 2.15
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 2.15
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 2.15
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 2.15
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.14
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 2.14
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 2.13
Androgen Receptor-regulated genes in prostate cancer cells 2.13
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 2.11
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 2.11
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 2.1
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 2.1
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 2.09
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 2.08
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 2.08
Transcriptome wide analysis of classically and alternatively activated macrophages 2.05
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 2.03
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 2.02
Tpl-2 small molecule project 1.93
Tpl-2 and MEK small molecule inhibitors 1.93
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.89
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.89
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.89
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.88
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 1.87
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 1.87
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 1.87
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 1.86
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.86
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 1.81
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.81
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.77
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.77
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 1.76
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.75
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.67
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 1.67
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.65
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 1.6
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.58
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 1.57
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 1.55
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.47
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 1.44
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 1.44
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 1.44
Deep RNA sequencing of the human placental transcriptome 1.42
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.39
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 1.38
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.38
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.37
Oncogenic roles of ARID5B in T-ALL 1.34
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.34
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.34
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 1.34
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 1.32
HNRNPM-regulated splicing dependencies in prostate cancer 1.32
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 1.29
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 1.26
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.23
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.22
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.2
Gene expression profile of CRC-derived HILEC 1.16
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 1.16
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 1.16
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 1.11
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.1
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 1.09
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.06
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.04
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.01
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 0.99
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.95
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.94
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.9
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 0.89
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.89
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.88
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.88
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.88
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.81
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 0.81
U2AF1 mutations alter splice site recognition in hematological malignancies 0.8
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 0.8
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 0.79
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.78
The pioneer factor CEBPA modulates vitamin D signaling 0.78
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.75
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.72
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.71
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.69
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 0.69
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.68
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.68
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.66
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.66
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.65
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.64
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.63
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.62
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.62
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.61
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.6
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 0.59
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.57
RNA-seq of primary patient AML samples 0.56
The transcriptome and chromatin accessbility landscape of mammalian germline 0.56
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 0.52
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.5
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.47
Dilated cardiomyopathy vs Myocarditis 0.47
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.46
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.46
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  0.45
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.45
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 0.44
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 0.44
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.35
Modulation of nonsense-mediated decay by rapamycin 0.34
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.33
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.33
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.33
Reprogrammed myeloid cell transcriptomes in NSCLC 0.33
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.31
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.31
Transcriptome of activated human and mouse MAIT cells 0.3
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.3
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.25
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.23
Expression analysis of the TAF1 syndrome 0.22
Subtle asymmetry of gene expression in embryonic and foetal human brains 0.21
Total RNA-Seq data from leukemic patients with complex structural variants 0.2
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.18
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.17
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.16
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.13
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.13
Specific molecular signatures underlie response to decitabine in CMML 0.13
KSDM1b Role in Ewing Sarcoma 0.13
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.1
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.1
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.1
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.07
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.05
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation